1. Home
  2. NUV vs SDGR Comparison

NUV vs SDGR Comparison

Compare NUV & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Municipal Value Fund Inc.

NUV

Nuveen Municipal Value Fund Inc.

N/A

Current Price

$8.39

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

N/A

Current Price

$26.93

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUV
SDGR
Founded
1987
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NUV
SDGR
Price
$8.39
$26.93
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $25.86
AVG Volume (30 Days)
1.5M
★ 2.3M
Earning Date
01-01-0001
11-04-2026
Dividend Yield
★ 3.96%
N/A
EPS Growth
N/A
★ 45.14
EPS
★ N/A
N/A
Revenue
N/A
★ $255,869,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.09
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 23.29
52 Week Low
$8.02
$10.95
52 Week High
$9.26
$33.78

Technical Indicators

Market Signals
Indicator
NUV
SDGR
Relative Strength Index (RSI) 52.95 52.53
Support Level $8.05 $11.27
Resistance Level $9.22 $31.59
Average True Range (ATR) 0.10 1.99
MACD 0.03 0.32
Stochastic Oscillator 93.10 55.89

Price Performance

Historical Comparison
NUV
SDGR

About NUV Nuveen Municipal Value Fund Inc.

Nuveen Municipal Value Fund Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: